Sanofi (ETR: SNW)
Germany
· Delayed Price · Currency is EUR 91.16
-0.11 (-0.12%)
Dec 20, 2024, 5:35 PM CET
Sanofi Employees
Sanofi had 86,088 employees as of December 31, 2023. The number of employees decreased by 5,485 or -5.99% compared to the previous year.
Employees
86,088
Change (1Y)
-5,485
Growth (1Y)
-5.99%
Revenue / Employee
€562,738
Profits / Employee
€52,342
Market Cap
114.43B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | 100,409 | -3,817 | -3.66% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sanofi News
- 1 day ago - Sanofi to buy China rights to Cytokinetics lead asset - Seeking Alpha
- 1 day ago - Cytokinetics Inc (CYTK) Announces Sanofi's Acquisition of Aficamten Rights in Greater China - GuruFocus
- 2 days ago - Presse release: Jean-Paul Kress to join Sanofi's Board of Directors - GlobeNewsWire
- 3 days ago - Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases - Benzinga
- 3 days ago - Sanofi and Teva Achieve Milestone in Ulcerative Colitis Treatment Study - GuruFocus
- 4 days ago - Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's - Investopedia
- 4 days ago - Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment - The Wall Street Journal
- 4 days ago - Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment - WSJ